CEL-SCI Corporation (CVM)

USD 0.2

(-6.42%)

Net Income Summary of CEL-SCI Corporation

  • CEL-SCI Corporation's latest annual net income in 2023 was -32.36 Million USD , up 15.87% from previous year.
  • CEL-SCI Corporation's latest quarterly net income in 2024 Q2 was -7.24 Million USD , down -7.98% from previous quarter.
  • CEL-SCI Corporation reported an annual net income of -38.26 Million USD in 2022, up 2.35% from previous year.
  • CEL-SCI Corporation reported an annual net income of -39.18 Million USD in 2021, down -21.61% from previous year.
  • CEL-SCI Corporation reported a quarterly net income of -6.85 Million USD for 2024 Q3, up 5.36% from previous quarter.
  • CEL-SCI Corporation reported a quarterly net income of -6.7 Million USD for 2024 Q1, up 12.07% from previous quarter.

Annual Net Income Chart of CEL-SCI Corporation (2023 - 1989)

Historical Annual Net Income of CEL-SCI Corporation (2023 - 1989)

Year Net Income Net Income Growth
2023 -32.36 Million USD 15.87%
2022 -38.26 Million USD 2.35%
2021 -39.18 Million USD -21.61%
2020 -32.22 Million USD -30.5%
2019 -24.69 Million USD 22.44%
2018 -31.83 Million USD -121.66%
2017 -14.36 Million USD -25.26%
2016 -11.46 Million USD 66.93%
2015 -34.67 Million USD -26.71%
2014 -27.36 Million USD -198.4%
2013 -9.17 Million USD 40.75%
2012 -15.47 Million USD 39.81%
2011 -25.71 Million USD -345.27%
2010 10.48 Million USD 125.63%
2009 -40.91 Million USD -431.06%
2008 -7.7 Million USD 20.0%
2007 -9.62 Million USD -21.29%
2006 -7.93 Million USD -161.19%
2005 -3.03 Million USD 27.62%
2004 -4.19 Million USD 34.09%
2003 -6.37 Million USD 23.62%
2002 -8.34 Million USD 22.28%
2001 -10.73 Million USD -26.6%
2000 -8.47 Million USD -13.05%
1999 -7.5 Million USD -17.19%
1998 -6.4 Million USD 21.95%
1997 -8.2 Million USD -30.16%
1996 -6.3 Million USD -61.54%
1995 -3.9 Million USD 11.36%
1994 -4.4 Million USD -83.33%
1993 -2.4 Million USD -41.18%
1992 -1.7 Million USD -41.67%
1991 -1.2 Million USD -33.33%
1990 -900 Thousand USD 18.18%
1989 -1.1 Million USD 15.38%

Peer Net Income Comparison of CEL-SCI Corporation

Name Net Income Net Income Difference
AIM ImmunoTech Inc. -28.96 Million USD -11.753%
Ampio Pharmaceuticals, Inc. -8.63 Million USD -274.952%
Armata Pharmaceuticals, Inc. -69.04 Million USD 53.124%
Actinium Pharmaceuticals, Inc. -48.81 Million USD 33.701%
Azitra, Inc. -11.28 Million USD -186.835%
Can-Fite BioPharma Ltd. -7.63 Million USD -323.97%
Chromocell Therapeutics Corporation -7.38 Million USD -338.515%
Calidi Biotherapeutics, Inc. -29.21 Million USD -10.781%
iBio, Inc. -24.9 Million USD -29.947%
Lineage Cell Therapeutics, Inc. -21.48 Million USD -50.637%
MAIA Biotechnology, Inc. -19.77 Million USD -63.688%
Matinas BioPharma Holdings, Inc. -22.94 Million USD -41.077%
Navidea Biopharmaceuticals, Inc. -15.17 Million USD -113.254%
NovaBay Pharmaceuticals, Inc. -9.64 Million USD -235.745%
NanoViricides, Inc. -8.29 Million USD -290.225%
Oragenics, Inc. -20.65 Million USD -56.692%
BiomX Inc. -26.16 Million USD -23.68%
BiomX Inc. -26.16 Million USD -23.68%
Protalix BioTherapeutics, Inc. 8.31 Million USD 489.387%
Palatin Technologies, Inc. -29.73 Million USD -8.844%
Scorpius Holdings, Inc. -45.21 Million USD 28.421%
Theriva Biologics, Inc. -18.34 Million USD -76.39%